PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33609497-4	2021	In this study, in vitro severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike pseudotyped viral infection experiments indicated that histamine H1 antagonists loratadine (LOR) and desloratadine (DES) could prevent entry of the pseudotyped virus into ACE2-overexpressing HEK293T cells and showed that DES was more effective.	desloratadine	192-205	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	85-90	
33609497-8	2021	To our knowledge, this study is the first to demonstrate the inhibitory effect of LOR and DES on SARS-CoV-2 spike pseudotyped virus viropexis by blocking spike protein-ACE2 interaction.	desloratadine	90-93	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	108-113	
33609497-8	2021	To our knowledge, this study is the first to demonstrate the inhibitory effect of LOR and DES on SARS-CoV-2 spike pseudotyped virus viropexis by blocking spike protein-ACE2 interaction.	desloratadine	90-93	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	154-159